Abbott Laboratories Inc. has won a nod for MR-conditional labeling on some of its most widely used high voltage devices. The FDA-approved labeling is for the Quadra Assura Mp Cardiac Resynchronization Therapy Defibrillator (CRTD) and Fortify Assura implantable cardioverter defibrillator (ICD).